Lexicon Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2019
Total Assets: $417.7M
Liabilities Breakdown FY2019
Total Liabilities: $300.6M
Asset Breakdown
Total Assets: $417.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $36.1M | 8.6% |
| Accounts Receivable | $56.5M | 13.5% |
| Inventory | $4.2M | 1.0% |
| Property, Plant & Equipment | $14.0M | 3.4% |
| Goodwill | $44.5M | 10.7% |
| Intangible Assets | $19.7M | 4.7% |
| Other Assets | $242.5M | 58.1% |
Liabilities Breakdown
Total Liabilities: $300.6M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.2M | 4.1% |
| Long-Term Debt | $234.2M | 77.9% |
| Other Liabilities | $54.3M | 18.1% |